# Research Statistics Dashboard - Visual Guide

## Page Layout Overview

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â† Back to Pesquisas                                                â”‚
â”‚                                                                       â”‚
â”‚  ðŸ”¬ Bloqueio do Nervo Pudendo em Hemorroidectomia      [Active]     â”‚
â”‚  Estudo comparativo de tÃ©cnicas...                                   â”‚
â”‚  Tipo de cirurgia: Hemorroidectomia                                  â”‚
â”‚                                                                       â”‚
â”‚  [ðŸ“„ Export PDF] [ðŸ“Š Export Data] [âœ‰ï¸ Email Report]                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ðŸ‘¥ 42   â”‚  ðŸ“Š 54.3 â”‚  âœ… 87%  â”‚ ðŸ“… Jan   â”‚ â° Activeâ”‚
â”‚ Patients â”‚   Age    â”‚Completudeâ”‚  2025    â”‚  Status  â”‚
â”‚  2 gruposâ”‚   anos   â”‚   Data   â”‚ 45 days  â”‚          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ [Overview] [Demographics] [Groups] [Outcomes] [Clinical Data]       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                       â”‚
â”‚  OVERVIEW TAB                                                         â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                       â”‚
â”‚  ðŸ“Š DistribuiÃ§Ã£o por Sexo          ðŸ“ˆ DistribuiÃ§Ã£o de Idade          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”           â”‚
â”‚  â”‚                     â”‚          â”‚     â–ˆâ–ˆâ–ˆ             â”‚           â”‚
â”‚  â”‚      â—â”€â”€â”€â”€â”€â—       â”‚          â”‚     â–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆ        â”‚           â”‚
â”‚  â”‚     /       \      â”‚          â”‚ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆ   â”‚           â”‚
â”‚  â”‚    /         \     â”‚          â”‚ A   B    A    B     â”‚           â”‚
â”‚  â”‚   /   60%     \    â”‚          â”‚ Min Avg  Max       â”‚           â”‚
â”‚  â”‚  /             \   â”‚          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜           â”‚
â”‚  â”‚ â— 40% Fem  Masc â— â”‚                                             â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                                            â”‚
â”‚                                                                       â”‚
â”‚  ðŸ“Š ComparaÃ§Ã£o entre Grupos                                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”           â”‚
â”‚  â”‚                                                        â”‚           â”‚
â”‚  â”‚  â–ˆâ–ˆâ–ˆ                                                   â”‚           â”‚
â”‚  â”‚  â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ                                               â”‚           â”‚
â”‚  â”‚  â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ                                           â”‚           â”‚
â”‚  â”‚  â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ                                       â”‚           â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                     â”‚           â”‚
â”‚  â”‚  Grp Grp Grp Grp                                       â”‚           â”‚
â”‚  â”‚  A   B   A   B                                         â”‚           â”‚
â”‚  â”‚  Pacientes  Idade  Taxa Resp                           â”‚           â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Demographics Tab View

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  GRUPO A: Grupo Controle         â”‚  GRUPO B: Bloqueio por Anatomia  â”‚
â”‚  Perfil demogrÃ¡fico do grupo     â”‚  Perfil demogrÃ¡fico do grupo     â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                   â”‚                                   â”‚
â”‚  ðŸ‘¥ 21 Pacientes   ðŸ“Š 52.4 anos  â”‚  ðŸ‘¥ 21 Pacientes   ðŸ“Š 56.2 anos  â”‚
â”‚                                   â”‚                                   â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                   â”‚                                   â”‚
â”‚  DistribuiÃ§Ã£o por Sexo:           â”‚  DistribuiÃ§Ã£o por Sexo:           â”‚
â”‚  Masculino   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  14    â”‚  Masculino   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  16   â”‚
â”‚  Feminino    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ      7    â”‚  Feminino    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ          5   â”‚
â”‚                                   â”‚                                   â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                   â”‚                                   â”‚
â”‚  Faixa EtÃ¡ria:                    â”‚  Faixa EtÃ¡ria:                    â”‚
â”‚  28 - 76 anos  [Amplitude: 48]   â”‚  31 - 78 anos  [Amplitude: 47]   â”‚
â”‚                                   â”‚                                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Outcomes Tab - Pain Progression

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ðŸ“ˆ EvoluÃ§Ã£o da Dor ao Longo do Tempo                                â”‚
â”‚  ComparaÃ§Ã£o dos nÃ­veis de dor entre grupos durante o follow-up       â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                       â”‚
â”‚  10â”‚                                                                  â”‚
â”‚   9â”‚  â—â”€â”€â”€â—                                                           â”‚
â”‚   8â”‚  â”‚    â•²                                                          â”‚
â”‚   7â”‚  â”‚     â—â”€â”€â”€â—  â† Grupo A (Controle)                              â”‚
â”‚   6â”‚  â”‚          â•²                                                    â”‚
â”‚   5â”‚  â—           â—â”€â”€â”€â—                                               â”‚
â”‚   4â”‚   â•²         /                                                    â”‚
â”‚   3â”‚    â—â”€â”€â”€â—â”€â”€â”€â—  â† Grupo B (Bloqueio)                              â”‚
â”‚   2â”‚                                                                  â”‚
â”‚   1â”‚                                                                  â”‚
â”‚   0â”‚                                                                  â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                    â”‚
â”‚     D+1  D+3  D+7  D+10  D+14  D+21  D+30                            â”‚
â”‚                                                                       â”‚
â”‚  ðŸ“Š Taxa de ComplicaÃ§Ãµes por Grupo                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                                     â”‚
â”‚  â”‚  Grupo A  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  12%     â”‚                                     â”‚
â”‚  â”‚  Grupo B  â–ˆâ–ˆâ–ˆâ–ˆ       5%     â”‚                                     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                                     â”‚
â”‚                                                                       â”‚
â”‚  âœ… Taxa de Resposta ao Follow-up                                    â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                                     â”‚
â”‚  â”‚  Grupo A  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ 85%  â”‚                                     â”‚
â”‚  â”‚  Grupo B  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ 90%â”‚                                     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Clinical Data Tab

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  GRUPO A: Grupo Controle         â”‚  GRUPO B: Bloqueio por Anatomia  â”‚
â”‚  Dados clÃ­nicos e comorbidades   â”‚  Dados clÃ­nicos e comorbidades   â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                   â”‚                                   â”‚
â”‚  ðŸ¥ Comorbidades                  â”‚  ðŸ¥ Comorbidades                  â”‚
â”‚  HAS        â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  11      â”‚  HAS        â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ     9      â”‚
â”‚  Diabetes   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ     9      â”‚  Diabetes   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ        6      â”‚
â”‚  Dislip.    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ        6      â”‚  Dislip.    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ         5      â”‚
â”‚  Obesidade  â–ˆâ–ˆâ–ˆâ–ˆ          4      â”‚  Obesidade  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ       7      â”‚
â”‚  Tabagismo  â–ˆâ–ˆâ–ˆ           3      â”‚  Tabagismo  â–ˆâ–ˆ            2      â”‚
â”‚                                   â”‚                                   â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                   â”‚                                   â”‚
â”‚  ðŸ’Š MedicaÃ§Ãµes Mais Comuns        â”‚  ðŸ’Š MedicaÃ§Ãµes Mais Comuns        â”‚
â”‚  Dipirona    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  12    â”‚  Dipirona    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   10     â”‚
â”‚  Tramadol    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    10    â”‚  Tramadol    â–ˆâ–ˆâ–ˆâ–ˆ          4     â”‚
â”‚  Omeprazol   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ      9    â”‚  Omeprazol   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ      8     â”‚
â”‚  Lactulose   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ        7    â”‚  Lactulose   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ     9     â”‚
â”‚  Metronidaz  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ          5    â”‚  Metronidaz  â–ˆâ–ˆâ–ˆâ–ˆ          4     â”‚
â”‚                                   â”‚                                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ðŸ“Š Testes EstatÃ­sticos                                              â”‚
â”‚  ComparaÃ§Ãµes estatÃ­sticas entre grupos                               â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                       â”‚
â”‚  Teste t para Idade                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚
â”‚  â”‚ t = -1.234 â”‚ MÃ©dia A    â”‚ MÃ©dia B    â”‚ DiferenÃ§a  â”‚              â”‚
â”‚  â”‚            â”‚ 52.4       â”‚ 56.2       â”‚ -3.8       â”‚              â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚
â”‚                                                                       â”‚
â”‚  â„¹ï¸ p > 0.05: NÃ£o hÃ¡ diferenÃ§a estatisticamente significativa       â”‚
â”‚     na idade entre os grupos.                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Export Options Modal

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ðŸ“„ Exportar RelatÃ³rio                   â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                           â”‚
â”‚  Selecione o formato:                    â”‚
â”‚                                           â”‚
â”‚  â—‹ PDF - RelatÃ³rio completo              â”‚
â”‚     Ideal para apresentaÃ§Ãµes             â”‚
â”‚                                           â”‚
â”‚  â— Excel - Dados brutos                  â”‚
â”‚     Para anÃ¡lise estatÃ­stica             â”‚
â”‚                                           â”‚
â”‚  â—‹ CSV - Dados tabulares                 â”‚
â”‚     CompatÃ­vel com todos softwares       â”‚
â”‚                                           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                           â”‚
â”‚  Incluir:                                 â”‚
â”‚  â˜‘ GrÃ¡ficos                              â”‚
â”‚  â˜‘ Tabelas de dados                      â”‚
â”‚  â˜‘ Testes estatÃ­sticos                   â”‚
â”‚  â˜‘ InformaÃ§Ãµes dos pacientes             â”‚
â”‚                                           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                           â”‚
â”‚  [Cancelar]           [Exportar]         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Mobile View (Responsive)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ â† Pesquisas                  â”‚
â”‚                              â”‚
â”‚ ðŸ”¬ Bloqueio do Nervo         â”‚
â”‚ Pudendo...                   â”‚
â”‚ [Active]                     â”‚
â”‚                              â”‚
â”‚ [...] Menu                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                              â”‚
â”‚ ðŸ‘¥ 42                        â”‚
â”‚ Total Pacientes              â”‚
â”‚ 2 grupos                     â”‚
â”‚                              â”‚
â”‚ ðŸ“Š 54.3                      â”‚
â”‚ Idade MÃ©dia                  â”‚
â”‚ anos                         â”‚
â”‚                              â”‚
â”‚ âœ… 87%                       â”‚
â”‚ Completude                   â”‚
â”‚                              â”‚
â”‚ ðŸ“… Jan 2025                  â”‚
â”‚ Data InÃ­cio                  â”‚
â”‚ 45 dias                      â”‚
â”‚                              â”‚
â”‚ â° Active                    â”‚
â”‚ Status                       â”‚
â”‚                              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ [Overview â–¼]                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                              â”‚
â”‚ ðŸ“Š DistribuiÃ§Ã£o por Sexo     â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚ â”‚      â—â”€â”€â”€â”€â”€â—         â”‚    â”‚
â”‚ â”‚     /       \        â”‚    â”‚
â”‚ â”‚    /  60%    \       â”‚    â”‚
â”‚ â”‚   â—  40%      â—      â”‚    â”‚
â”‚ â”‚   Fem         Masc   â”‚    â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                              â”‚
â”‚ (Scroll down for more...)    â”‚
â”‚                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Color Legend

### Primary Elements
```
Navy Blue (#0A2647)    â–ˆâ–ˆâ–ˆâ–ˆ  Headers, Buttons
Medium Blue (#2C74B3)  â–ˆâ–ˆâ–ˆâ–ˆ  Secondary
Light Blue (#5AB2FF)   â–ˆâ–ˆâ–ˆâ–ˆ  Accents
Sky Blue (#9DD4FF)     â–ˆâ–ˆâ–ˆâ–ˆ  Highlights
```

### Status Colors
```
Green (#22c55e)        â–ˆâ–ˆâ–ˆâ–ˆ  Success, Low Risk
Yellow (#eab308)       â–ˆâ–ˆâ–ˆâ–ˆ  Warning, Medium
Orange (#f97316)       â–ˆâ–ˆâ–ˆâ–ˆ  High Risk
Red (#ef4444)          â–ˆâ–ˆâ–ˆâ–ˆ  Critical, Complications
```

### Background Colors
```
Blue-50                â–ˆâ–ˆâ–ˆâ–ˆ  Info cards
Purple-50              â–ˆâ–ˆâ–ˆâ–ˆ  Age cards
Green-50               â–ˆâ–ˆâ–ˆâ–ˆ  Success cards
Gray-50                â–ˆâ–ˆâ–ˆâ–ˆ  Neutral cards
White                  â–ˆâ–ˆâ–ˆâ–ˆ  Main background
```

## Icon Legend

- ðŸ”¬ **FlaskConical**: Research/Study
- ðŸ‘¥ **Users**: Patients/Participants
- ðŸ“Š **Activity**: Age/Metrics
- âœ… **CheckCircle2**: Completeness/Success
- ðŸ“… **Calendar**: Dates
- â° **Clock**: Status/Time
- ðŸ“ˆ **TrendingUp**: Trends/Growth
- ðŸ“„ **Download**: Export/Download
- âœ‰ï¸ **Mail**: Email
- ðŸ¥ **AlertCircle**: Complications/Alerts
- ðŸ’Š **Activity**: Medications
- ðŸ“Š **BarChart3**: Statistics/Charts
- ðŸ”™ **ChevronLeft**: Back/Navigation

## Interactive Elements

### Hover Effects
```
Button:
  Normal:   [Button Text]
  Hover:    [Button Text] â† Slightly darker
  Active:   [Button Text] â† Even darker
  Disabled: [Button Text] â† Grayed out
```

### Chart Tooltips
```
Hover on chart element:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Grupo A              â”‚
â”‚ Dia: D+7             â”‚
â”‚ Dor: 5/10            â”‚
â”‚ Taxa: 85%            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Loading States
```
Loading...
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                          â”‚
â”‚    âŸ³ Carregando...      â”‚
â”‚    EstatÃ­sticas          â”‚
â”‚                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Error States
```
Error
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    âš ï¸                    â”‚
â”‚    Erro ao carregar      â”‚
â”‚    estatÃ­sticas          â”‚
â”‚                          â”‚
â”‚    [Tentar Novamente]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Navigation Flow

```
Dashboard
    â”‚
    â””â”€> Pesquisas (List)
            â”‚
            â”œâ”€> [Nova Pesquisa] â†’ Create Form â†’ Back to List
            â”‚
            â””â”€> [EstatÃ­sticas] â†’ Statistics Page
                    â”‚
                    â”œâ”€> Overview Tab
                    â”œâ”€> Demographics Tab
                    â”œâ”€> Groups Tab
                    â”œâ”€> Outcomes Tab
                    â”œâ”€> Clinical Data Tab
                    â”‚
                    â”œâ”€> [Export PDF]     â†’ Download
                    â”œâ”€> [Export Data]    â†’ Download
                    â””â”€> [Email Report]   â†’ Send Email
```

## Keyboard Shortcuts

- `Tab`: Navigate between elements
- `Enter`: Activate button/link
- `Esc`: Close modal/dialog
- `Arrow Keys`: Navigate tabs
- `Space`: Toggle checkboxes

## Print View

When printing (Ctrl+P):
- Headers optimized for paper
- Charts rendered in high quality
- Tables formatted for readability
- Colors adjusted for B&W printing
- Page breaks at logical points

---

**Note**: This is a text representation. The actual implementation uses
beautiful Recharts visualizations with smooth animations and interactive
tooltips for a professional, modern research dashboard experience.
